TRV GP V, LLC — Q4 2025 13F-HR

← TRV GP V, LLC

Q4 2025 · 13F-HR

TRV GP V, LLCholdings as filed

Filed 2026-02-13 · accession 0001193125-26-051785

$429.2M

Reported value

Positions

2025-12-31

Period end

View analyzed profile →PRO

The Brief · TRV GP V, LLC · Q4 2025

AI · grounded in 13F

TRV GP V, LLC reported no changes to its 13F holdings for 2025-12-31 relative to 2025-09-30.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
75383L102	RAPP	RAPPORT THERAPEUTICS, INC.	$216.5M	50.4%	7,135,233	Common	SOLE
81734D104	SEPN	SEPTERNA, INC.	$173.3M	40.4%	6,215,591	Common	SOLE
578784100	MAZE	MAZE THERAPEUTICS, INC.	$39.4M	9.18%	950,800	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.